top of page

GSK Salbutamol Programme

Project Description:


M2 Build is an Oral Solid Dose facility (OSD), producing tablets and capsules for the GSK brand. 


The project was a blend of modular design (DFMA) and traditional ‘stick built’ construction.



Key Challenges:

  • Providing a GMP environment

  • DFMA Modular Design


Should you wish to know more about our role on Science, Research and Healthcare projects, please contact

iM2 Role: Principal Designer

Project Team:


Simons Design Ltd

Shepherd Gilmore

NG Bailey


Sector: Science, Research & Healthcare

Start Date: July 2020

Completion: January 2023

Value: (£) Confidential

Screenshot 2021-09-22 at 17.28.51.png
Screenshot 2021-09-22 at 17.28.58.png
APS-logo White.jpg
iM2 Limited
Hamilton House
Mabledon Place
London, WC1H 9BB
England, UK
  • X
  • LinkedIn

0203 972 4157

iM2 LOGO ISSUE A OUTLINES 25-05-20.png
bottom of page